The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 15, 2021
Filed:
Mar. 23, 2018
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Liangqin Guo, Monroe Township, NJ (US);
Yongxin Han, Needham, MA (US);
Kun Liu, Needham, MA (US);
Shuwen He, Fanwood, NJ (US);
Joseph Kozlowski, Princeton, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Wensheng Yu, Edison, NJ (US);
Hongjun Zhang, Boston, MA (US);
Qinglin Pu, Needham, MA (US);
Derun LI, Brighton, MA (US);
Abdelghani Achab, Melrose, MA (US);
Guoqing LI, Belle Mead, NJ (US);
Liangqin Guo, Monroe Township, NJ (US);
Yongxin Han, Needham, MA (US);
Kun Liu, Needham, MA (US);
Shuwen He, Fanwood, NJ (US);
Joseph Kozlowski, Princeton, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Wensheng Yu, Edison, NJ (US);
Hongjun Zhang, Boston, MA (US);
Qinglin Pu, Needham, MA (US);
Derun Li, Brighton, MA (US);
Abdelghani Achab, Melrose, MA (US);
Guoqing Li, Belle Mead, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof. Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.